Clinical Trial Update: Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of the obesity drug GZR18 in individuals with normal renal function and renal impairment; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GZR18

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Obesity/Overweight | Phase 1 | Status: RECRUITING